ERS - Annual Presidential Summit
The European Respiratory Society (ERS) recently hosted its annual Presidential Summit in Rome to coincide with the Italian Presidency of the EU, which focused on breaking down barriers to the development of new medicines.
There is currently a lack of new medicines in the field of lung health, and the Summit provided the chance to address key areas in improving the research and the European regulation for new medicines. The ERS Roadmap, published in 2010, identified that only five novel classes of therapy have been developed over the past 40 years, which is fewer than in any other therapeutic area.
During the summit, presentations from lung health professionals, stakeholder representatives and policy-makers shed light on the current challenges and explored new ways to change this environment. Two patients who have been involved in research as participants also took to the stage to share their perspectives on clinical trials and drug development.
A paper summarising the main outcomes of the Summit will be published later this year.
Last updated on 23 July 2014